LCD ID Number: L36912 Status: A-Approved
LCD Title: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
Geographic Jurisdiction: Alabama Other Jurisdictions
Original Determination Effective Date:
03/06/2017
Original Determination Ending Date:
Revision Effective Date:
11/25/2021
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act §1862(a)(1)(A) allows coverage and payment for those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
42 Code of Federal Regulations (CFR) 410.32(a) Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions.
CMS Internet Only Manuals, Pub 100-02 Medicare Beneficiary Policy Manual Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|